HealthEquity (HQY) earnings per share (EPS)

Earnings per share · fiscal 2026
$2.46

HealthEquity (HQY) reported diluted earnings per share of $2.46 in fiscal 2026 (the year ended January 31, 2026). That is 125.7% higher than the $1.09 of fiscal 2025. Figures as of 18 Nov 2026, 01:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2026
$2.46
Change on fiscal 2025
+125.7%
Growth, 5 years
+83.0% a year
Growth, 10 years
+24.3% a year
Highest on record
$2.46fiscal 2026
Lowest on record
-$1.26fiscal 2014
Fiscal years on record
142013–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

HealthEquity earnings per share (EPS), in more detail

Over the five fiscal years to 2026 diluted earnings per share grew at a compound 83.0% a year; over ten years the rate was 24.3% a year. Across the 14 fiscal years on record (2013–2026), the highest was $2.46 in fiscal 2026 and the lowest -$1.26 in fiscal 2014.

History · 14 fiscal years

Earnings per share by fiscal year

HealthEquity earnings per share (EPS), year by year

HealthEquity (HQY) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2026$2.46 125.7% up
2025$1.09 70.3% up
2024$0.64—
2023-$0.31—
2022-$0.53 541.7% down
2021$0.12 79.3% down
2020$0.58 50.4% down
2019$1.17 51.9% up
2018$0.77 75.0% up
2017$0.44 57.1% up
2016$0.28 33.3% up
2015$0.21—
2014-$1.26 604.0% down
2013$0.25—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of HealthEquity and comparable companies
CompanyEarnings per shareFiscal year
Twist Bioscience TWST-$1.302025
Protagonist Therapeutics PTGX-$2.052025
Krystal Biotech KRYS$6.842025
10x Genomics TXG-$0.352025
HealthEquity HQY$2.462026
Corcept Therapeutics CORT$0.822025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on HQY

HealthEquity, figure by figure

HealthEquity (HQY) overview: price, valuation and scorecardAll health care companies by market value

HealthEquity earnings per share (EPS): questions and answers

What is HealthEquity's diluted earnings per share?

HealthEquity (HQY) reported diluted earnings per share of $2.46 in fiscal 2026 (the year ended January 31, 2026). That is 125.7% higher than the $1.09 of fiscal 2025.

What is the growth rate of HealthEquity's diluted earnings per share?

Over the five fiscal years to 2026 diluted earnings per share grew at a compound 83.0% a year; over ten years the rate was 24.3% a year.

What are the highest and lowest diluted earnings per share figures on record for HealthEquity?

Across the 14 fiscal years on record (2013–2026), the highest was $2.46 in fiscal 2026 and the lowest -$1.26 in fiscal 2014.

How is HealthEquity's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “HealthEquity (HQY) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/HQY/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.